Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment

BACKGROUND: In this study we compare the Omalizumab treatment modality in the dynamics of cell apoptosis regulating molecules in both severe persistent asthma patients who had no other any allergic disease, newly diagnosed patients with allergic asthma, and healthy volunteers. MATERIAL/METHODS: Seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalcin, Arzu Didem, Bisgin, Atil, Kargi, Aysegul, Gorczynski, Reginald M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Public Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560751/
https://www.ncbi.nlm.nih.gov/pubmed/22367138
http://dx.doi.org/10.12659/MSM.882504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560751/
https://www.ncbi.nlm.nih.gov/pubmed/22367138
http://dx.doi.org/10.12659/MSM.882504

Ejemplares similares